JP6289218B2 - Method for activating PPARα active composition - Google Patents
Method for activating PPARα active composition Download PDFInfo
- Publication number
- JP6289218B2 JP6289218B2 JP2014074190A JP2014074190A JP6289218B2 JP 6289218 B2 JP6289218 B2 JP 6289218B2 JP 2014074190 A JP2014074190 A JP 2014074190A JP 2014074190 A JP2014074190 A JP 2014074190A JP 6289218 B2 JP6289218 B2 JP 6289218B2
- Authority
- JP
- Japan
- Prior art keywords
- ppar
- activity
- active
- pparα
- active composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 102000023984 PPAR alpha Human genes 0.000 title claims description 36
- 239000000203 mixture Substances 0.000 title claims description 30
- 108091008725 peroxisome proliferator-activated receptors alpha Proteins 0.000 title claims description 25
- 238000000034 method Methods 0.000 title claims description 17
- 230000003213 activating effect Effects 0.000 title claims description 7
- 230000000694 effects Effects 0.000 claims description 46
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 40
- 229910052799 carbon Inorganic materials 0.000 claims description 27
- 239000000126 substance Substances 0.000 claims description 23
- 240000000111 Saccharum officinarum Species 0.000 claims description 18
- 235000007201 Saccharum officinarum Nutrition 0.000 claims description 18
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 16
- 239000003463 adsorbent Substances 0.000 claims description 16
- 230000002401 inhibitory effect Effects 0.000 claims description 11
- 239000000419 plant extract Substances 0.000 claims description 11
- 241000196324 Embryophyta Species 0.000 claims description 10
- 238000000605 extraction Methods 0.000 claims description 10
- 239000002904 solvent Substances 0.000 claims description 10
- 244000025254 Cannabis sativa Species 0.000 claims description 9
- 240000006394 Sorghum bicolor Species 0.000 claims description 7
- 235000011684 Sorghum saccharatum Nutrition 0.000 claims description 6
- 238000004587 chromatography analysis Methods 0.000 claims description 6
- 241000209504 Poaceae Species 0.000 claims description 5
- 240000008042 Zea mays Species 0.000 claims description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 4
- 235000005822 corn Nutrition 0.000 claims description 4
- 102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 description 40
- 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 description 40
- 239000013543 active substance Substances 0.000 description 23
- 239000000284 extract Substances 0.000 description 20
- 238000001179 sorption measurement Methods 0.000 description 15
- 108010028924 PPAR alpha Proteins 0.000 description 11
- 239000003112 inhibitor Substances 0.000 description 10
- 238000000926 separation method Methods 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 229910002804 graphite Inorganic materials 0.000 description 9
- 239000010439 graphite Substances 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 230000027455 binding Effects 0.000 description 4
- 239000003446 ligand Substances 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000002699 waste material Substances 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 239000003575 carbonaceous material Substances 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 239000000945 filler Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 208000001145 Metabolic Syndrome Diseases 0.000 description 2
- 108010015181 PPAR delta Proteins 0.000 description 2
- 108010016731 PPAR gamma Proteins 0.000 description 2
- 102000000536 PPAR gamma Human genes 0.000 description 2
- 102000001708 Protein Isoforms Human genes 0.000 description 2
- 108010029485 Protein Isoforms Proteins 0.000 description 2
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 210000001789 adipocyte Anatomy 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000002808 molecular sieve Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 2
- 238000002336 sorption--desorption measurement Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 102000007592 Apolipoproteins Human genes 0.000 description 1
- 108010071619 Apolipoproteins Proteins 0.000 description 1
- 102100037458 Dephospho-CoA kinase Human genes 0.000 description 1
- 102000030914 Fatty Acid-Binding Human genes 0.000 description 1
- 102100039556 Galectin-4 Human genes 0.000 description 1
- 101000608765 Homo sapiens Galectin-4 Proteins 0.000 description 1
- 108010013563 Lipoprotein Lipase Proteins 0.000 description 1
- 102100022119 Lipoprotein lipase Human genes 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- 108010044210 PPAR-beta Proteins 0.000 description 1
- 101000650578 Salmonella phage P22 Regulatory protein C3 Proteins 0.000 description 1
- 102000007451 Steroid Receptors Human genes 0.000 description 1
- 108010085012 Steroid Receptors Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 101001040920 Triticum aestivum Alpha-amylase inhibitor 0.28 Proteins 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 108010049285 dephospho-CoA kinase Proteins 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 108091022862 fatty acid binding Proteins 0.000 description 1
- 230000004129 fatty acid metabolism Effects 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000010189 intracellular transport Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 102000006255 nuclear receptors Human genes 0.000 description 1
- 108020004017 nuclear receptors Proteins 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003614 peroxisome proliferator Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000159 protein binding assay Methods 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 102000027483 retinoid hormone receptors Human genes 0.000 description 1
- 108091008679 retinoid hormone receptors Proteins 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 102000004217 thyroid hormone receptors Human genes 0.000 description 1
- 108090000721 thyroid hormone receptors Proteins 0.000 description 1
Images
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Description
本発明は、本発明は、ペルオキシソーム増殖剤応答性受容体(peroxisome proliferator−activated receptor:PPAR)活性組成物の活性化方法として特にPPARα活性組成物の活性化方法に関する。 The present invention relates to a method for activating a PPARα active composition, particularly as a method for activating a peroxisome proliferator-activated receptor (PPAR) active composition.
PPARは、ステロイド受容体、レチノイド受容体やサイロイド受容体等と同様、核内受容体スーパーファミリーに属するリガンド依存性の転写因子であり、これまでに組織分布を異にする三種のアイソフォーム(α型、δ(またはβ)型、γ型)がヒトをはじめ種々の動物種で同定されている(非特許文献1を参照)。この内PPARαは、脂肪酸の異化能の高い肝臓や腎臓、骨格筋等に発現しており、特に肝臓において高発現が認められ(非特許文献2を参照)、脂肪酸の代謝や細胞内輸送に関連する遺伝子(たとえば、アシルCoA合成酵素、脂肪酸結合タンパク質やリポ蛋白リパーゼなど)およびコレステロールや中性脂質の代謝に関連するアポリポ蛋白(AI、AII、CIII)遺伝子の発現を正または負に制御している。PPARδは、神経細胞を中心として生体内各組織に普遍的に発現している。現時点ではPPARδの生理的意義については不明である。PPARγは、脂肪細胞に高発現していて脂肪細胞の分化に関与している(非特許文献3を参照)。このようにPPARの各アイソフォームは特定の臓器や組織において特異的な機能を果たしている。 PPAR is a ligand-dependent transcription factor belonging to the nuclear receptor superfamily, like steroid receptors, retinoid receptors and thyroid receptors, and so far three isoforms (α Type, δ (or β) type, and γ type) have been identified in various animal species including humans (see Non-Patent Document 1). Among these, PPARα is expressed in the liver, kidney, skeletal muscle and the like having high fatty acid catabolism, and is particularly highly expressed in the liver (see Non-Patent Document 2), and is related to fatty acid metabolism and intracellular transport. By positively or negatively controlling the expression of genes (eg, acyl CoA synthase, fatty acid binding protein, lipoprotein lipase, etc.) and apolipoprotein (AI, AII, CIII) genes related to cholesterol and neutral lipid metabolism Yes. PPARδ is ubiquitously expressed in each tissue in the body centering on nerve cells. At present, the physiological significance of PPARδ is unknown. PPARγ is highly expressed in adipocytes and is involved in adipocyte differentiation (see Non-Patent Document 3). Thus, each isoform of PPAR performs a specific function in a specific organ or tissue.
このようなPPAR活性組成物が、イネ科植物に含有されていることは知られており、具体的にモロコシ属植物に含まれているPPAR活性組成物の抽出物は特許文献1に記載されている。ところが、一般に、同じ科に属する植物であっても、属が異なる植物が、同種の活性物質を生産するとしても、その活性物質が、他の属の植物から得られた活性物質と同等の活性を有するとは限らず、また、何らかの要因で活性が阻害されている場合もありえる。そのため、このような活性物質を探索する場合には、植物ごとに特有の抽出手法、分離手法を開発しなければならないことも多く、容易に活性物質を開発することができるわけではない。 It is known that such a PPAR active composition is contained in a grass family plant. Specifically, an extract of a PPAR active composition contained in a sorghum plant is described in Patent Document 1. Yes. However, in general, even if a plant belongs to the same family or a plant of a different genus produces the same type of active substance, the active substance has an activity equivalent to that of an active substance obtained from a plant of another genus. The activity may not be inhibited by some factor. Therefore, when searching for such active substances, it is often necessary to develop extraction methods and separation methods peculiar to each plant, and active substances cannot be easily developed.
そこで、本発明者らは、簡易な手法で効率よく得ることができるペルオキシソーム増殖剤応答性受容体(PPAR)活性組成物を提供することを目的としてサトウキビ由来のPPAR組成物を先に見出している(特許文献2)。 Therefore, the present inventors have previously found a PPAR composition derived from sugarcane for the purpose of providing a peroxisome proliferator-responsive receptor (PPAR) active composition that can be efficiently obtained by a simple technique. (Patent Document 2).
しかし、特許文献2の構成によると、上記サトウキビ由来PPAR組成物には、阻害物質が含まれることがわかっており、その阻害物質により、PPAR組成物の活性が抑制されているため、この阻害物質を有効に低減させ、PPAR組成物の活性を向上することが求められる。 However, according to the configuration of Patent Document 2, it is known that the sugarcane-derived PPAR composition contains an inhibitory substance, and the inhibitory substance suppresses the activity of the PPAR composition. Is required to be effectively reduced and the activity of the PPAR composition is improved.
そこで、本発明の目的は、上記サトウキビ等イネ科植物由来PPAR組成物に含まれる阻害物質を効率よく除去し、活性の高いPPAR組成物を得る点にある。 Therefore, an object of the present invention is to efficiently remove an inhibitor contained in the above-mentioned PPAR composition derived from a grass family such as sugarcane to obtain a highly active PPAR composition.
〔構成1〕
そこで、上記課題を解決するための本発明の特徴構成は、サトウキビ、ソルガム、トウモロコシから選ばれるいずれかのイネ科植物の梢頭部を、アセトンを含む抽出溶媒により抽出して得られるイネ科植物抽出物を主成分とするPPARα活性組成物の活性化方法であって、前記イネ科植物抽出物を炭素吸着材に接触させる工程を含む点にある。
[Configuration 1]
Therefore, a characteristic configuration of the present invention for solving the above-described problem is that a grass plant extract obtained by extracting the top of a grass plant selected from sugarcane, sorghum, and corn with an extraction solvent containing acetone. It is a method for activating a PPARα active composition containing a product as a main component, which comprises a step of bringing the grass plant extract into contact with a carbon adsorbent.
〔作用効果1〕
上記目的のため本発明者等は、鋭意研究の結果、サトウキビおよびソルガムに充分高いPPAR活性物質が含まれていることを明らかにした(特許文献2参照)。特に、サトウキビでは、製糖過程で捨てられている梢頭部からアセトンを含む抽出溶媒により抽出した抽出液にPPARα活性を見出した。
[Operation effect 1]
As a result of intensive studies, the present inventors have clarified that sugarcane and sorghum contain sufficiently high PPAR active substances (see Patent Document 2). In particular, in sugarcane, PPARα activity was found in an extract extracted from a top of the treetop that was discarded during the sugar production process using an extraction solvent containing acetone .
なお、本発明でいうPPAR活性物質とは、PPARのリガンド結合領域に結合する能力(活性)を有する化合物を含む物質であり、PPAR活性組成物とは、このような物質を成分として含有し、上記活性を備えた組成物をさす。PPARリガンド活性は、たとえば、PPARリガンド結合領域とGAL4との融合タンパクに対する結合をルシフェラーゼの発現で評価するレポーター・アッセイ(Cell,1995年,83巻,803〜812頁)や、PPARリガンド結合領域を含むタンパクを用いたコンペティション・バインディング・アッセイ(Cell,1995年,83巻,813〜819頁)などにより測定することができる。これらのアッセイにおいて、サンプルの活性は一般に溶媒対照と比較し、溶媒対照よりも高い活性を示し、なおかつ用量依存性が認められるサンプルを「PPAR活性あり」と評価する。 The PPAR active substance referred to in the present invention is a substance containing a compound having the ability (activity) to bind to the ligand binding region of PPAR, and the PPAR active composition contains such a substance as a component, It refers to a composition having the above activity. PPAR ligand activity can be determined by, for example, a reporter assay (Cell, 1995, 83, 803-812) for evaluating the binding of a PPAR ligand binding region to a GAL4 fusion protein by expression of luciferase, It can be measured by a competition binding assay (Cell, 1995, 83, 813-819) or the like using a protein containing the protein. In these assays, the activity of the sample is generally compared to the solvent control, and a sample that exhibits higher activity than the solvent control and is found to be dose-dependent is evaluated as “with PPAR activity”.
また、得られたイネ科植物抽出液には、活性阻害物質を含有していることがわかっている。PPAR活性物質については、物質として構造決定されているものもあるが、実際には活性だけが確認され、構造不明なものも多く、活性阻害物質についても、どのようなPPAR活性物質に対して、どのような構造の物質が活性阻害物質として働くのかは明らかになっていない。 Moreover, it is known that the obtained gramineous plant extract contains an activity inhibitory substance. Some PPAR active substances have a structure determined as a substance, but in reality, only the activity is confirmed, many structures are unknown, and the activity inhibitory substance also has any PPAR active substance. It is not clear what structure of the substance works as an activity inhibitor.
しかし本発明者らが鋭意研究した結果、PPARα活性物質が活性阻害物質と共存するPPARα活性組成物に炭素吸着材を作用させると、PPARα活性組成物のPPARα活性が向上することを見出した。これは、活性阻害物質が炭素吸着材に対して不安定であるか、吸着性が高いのに対し、PPARα活性物質が活性阻害物質に比べて炭素吸着材に対して安定で、吸着しにくいという性質を有していることによると考えられる。この性質を利用することにより、イネ科植物抽出液中から活性阻害物質を除去することができるので、PPARα活性物質の活性が有効に引き出せる。 However the present inventors have made extensive research and the action of carbon adsorbent PPAR alpha active composition PPAR alpha active substance coexists with active inhibitor that improves the PPAR alpha activity of PPAR alpha active composition I found it. This, the active inhibitor is unstable with respect to carbon adsorbent, while a high adsorptivity, stable to carbon adsorbent PPAR alpha active substance compared to the active inhibitor, hardly adsorbed This is thought to be due to the nature of By utilizing this property, it is possible to remove the active inhibitors from grass extract, the activity of the PPAR alpha active substance is effectively draw.
尚、炭素吸着材としては、多孔質グラファイトカーボン、活性炭、炭素分子ふるい等の種々公知の炭素系材料が利用でき、PPAR活性物質、活性阻害物質に対して同様に作用するものと考えられる。 As the carbon adsorbent, various known carbon-based materials such as porous graphite carbon, activated carbon, carbon molecular sieve and the like can be used, and it is considered that the carbon adsorbent acts on the PPAR active substance and the activity inhibiting substance in the same manner.
イネ科植物として、サトウキビ、ソルガム、トウモロコシを対象としてPPAR活性物
質を抽出する場合、その梢頭部を抽出することによってPPAR活性物質が有効に抽出で
きる。この梢頭部は、たとえばサトウキビにおいては精糖工程で最初に廃棄される部分で
あり、資源としては容易に確保することができるものである。また、単純に廃棄される廃
棄物から、PPAR活性組成物を抽出することができれば、廃棄物の有効利用を図ること
ができるとともに、廃棄にかかるエネルギーコストの節約につながる。
As Lee Ne Plants, sugarcane, sorghum, when extracting PPAR active substance as a target corn, PPAR active substance by extracting the treetops head can be effectively extracted. For example, in sugarcane, the top of the treetop is a part that is discarded first in the sugar refining process, and can be easily secured as a resource. Further, if the PPAR active composition can be extracted from the waste that is simply discarded, the waste can be effectively used and the energy cost for disposal can be saved.
なお、梢頭部とは、植物の成長する尖端部で、サトウキビであれば、先端から二節程度の糖度の低い部分をさす。サトウキビの梢頭部は、通常廃棄処分されている。 The top of the treetop is the apex where the plant grows, and if it is sugar cane, it refers to a portion with a low sugar content of about two nodes from the tip. Sugarcane treetops are usually discarded.
上記PPAR活性物質は、PPARα、PPARβ、PPARγいずれも含むが、現状で最も用途が確立している物質がPPARα活性物質である。そこで、後述の実施形態より、サトウキビ、ソルガム、トウモロコシから選ばれるいずれかのイネ科植物の梢頭部をアセトンを含む抽出溶媒により抽出した場合に、特にPPARα活性物質が効率よく抽出される。 The PPAR active substance includes any of PPARα, PPARβ, and PPARγ, and the PPARα active substance is the most established substance at present. Therefore, from the embodiments described later, when the top of a gramineous plant selected from sugarcane, sorghum and corn is extracted with an extraction solvent containing acetone, the PPARα active substance is particularly efficiently extracted.
PPARα活性を有する画分を得ることにより、PPARα活性物質を単離同定し、より活性を高めて利用することができる可能性があり、物質単位にまで単離するまでもなく、PPAR活性組成物として、より活性の高い状態で使用することが可能となる。 By obtaining a fraction having PPARα activity, it is possible to isolate and identify a PPARα active substance and use it with higher activity. As a result, it can be used in a more active state.
〔構成2〕
また、前記イネ科植物抽出物をクロマトグラフ法により分離し、PPARα活性阻害物質を除去する工程を含むことが好ましい。
[Configuration 2 ]
In addition, it is preferable to include a step of separating the Gramineae plant extract by a chromatographic method and removing a PPAR α activity inhibitory substance.
〔作用効果2〕
前記抽出物のPPARα活性を有する画分を、クロマトグラフ法により分離することにより、PPARα活性組成物を活性阻害のない高活性な状態で利用することができるようになる。
[Function and effect 2 ]
Fractions with PPAR alpha activity of the extract by separating by chromatography, it is possible to utilize a PPAR alpha active composition in a highly active state with no activity inhibition.
なお、クロマトグラフ法によりPPAR活性阻害物質を除去する工程は、炭素吸着材に接触させる工程に先立って行ってもよいし、炭素吸着材に接触させる工程の後に行ってもよい。いずれの場合であってもPPAR活性阻害物質を除去してPPAR活性組成物を高活性な状態とすることができる。 Note that the step of removing the PPAR activity inhibitor by the chromatographic method may be performed prior to the step of contacting the carbon adsorbent or after the step of contacting the carbon adsorbent. In any case, the PPAR activity inhibitor can be removed to make the PPAR active composition highly active.
したがって、サトウキビ等の廃材から少量で有効となるPPARα活性成分を得ることができ、メタボリックシンドローム改善の健康食品や飲料および医薬品としての活用が可能となる。 Therefore, it is possible to obtain a PPAR alpha active ingredient to be effective in small amounts from waste materials such as sugarcane, it is possible to use as a health food and beverage and pharmaceutical metabolic syndrome improved.
以下に、本発明のPPAR活性組成物を説明する。なお、以下に好適な実施例を記すが、これら実施例はそれぞれ、本発明をより具体的に例示するために記載されたものであって、本発明の趣旨を逸脱しない範囲において種々変更が可能であり、本発明は、以下の記載に限定されるものではない。 Below, the PPAR active composition of this invention is demonstrated. In addition, although suitable examples are described below, these examples are described in order to more specifically illustrate the present invention, and various modifications can be made without departing from the spirit of the present invention. The present invention is not limited to the following description.
〔PPAR活性組成物の抽出〕
サトウキビの梢頭部を、アセトンを含む抽出溶媒により抽出し(抽出工程)、得られた抽出成分を炭素吸着材に接触させる(吸着工程)さらに、クロロホルム、メタノール混合溶媒を溶出液としたクロマトグラフ法により分離する(カラム分離工程)。これにより、高メタノール溶媒抽出画分として、PPAR活性組成物を抽出することができる。
[Extraction of PPAR active composition]
Extract the sugarcane treetop with an extraction solvent containing acetone (extraction process), and contact the resulting extract with a carbon adsorbent (adsorption process). (Column separation step). Thereby, a PPAR active composition can be extracted as a high methanol solvent extraction fraction.
<抽出工程>
サトウキビ梢頭部を選別し、十分に乾燥させたものを細断、粉砕して抽出用試料を得た。試料20gを70%アセトン400mLに懸濁し、室温で16時間撹拌した後遠心分離して上清を回収した。さらに70%アセトン200mLに懸濁し、遠心分離して上清を回収する操作を10回繰り返し、すべての上清を併せて抽出液とした。抽出液は減圧下で濃縮し、10回分(サトウキビ梢頭部200g分)をまとめて300mlまで濃縮し、アセトンを除去した後、ジエチルエーテル200mlで2回抽出し、減圧下で濃縮乾固させ、2.43gの抽出物(イネ科植物抽出物)を得た。抽出物をクロロホルム20mLに溶解し、PPAR活性組成物を含有する抽出液を得た。
<Extraction process>
A sugarcane treetop was selected, and the dried sample was chopped and ground to obtain a sample for extraction. 20 g of the sample was suspended in 400 mL of 70% acetone, stirred for 16 hours at room temperature, and then centrifuged to recover the supernatant. Furthermore, the operation of suspending in 200 mL of 70% acetone, centrifuging, and collecting the supernatant was repeated 10 times, and all the supernatants were combined into an extract. The extract was concentrated under reduced pressure, and 10 portions (200 g of sugarcane treetop) were concentrated together to 300 ml, acetone was removed, then extracted twice with 200 ml of diethyl ether, concentrated to dryness under reduced pressure, 2 .43 g of extract (Poaceae extract) was obtained. The extract was dissolved in 20 mL of chloroform to obtain an extract containing the PPAR active composition.
<吸着工程>
得られた抽出液0.5mlを下記グラファイトカーボンカラムに添加した後、さらにメタノール20mLにて溶出させ、溶出液を濃縮乾固して抽出物を得た。
得られた抽出物を、使用した抽出液0.5mLあたり5mLのクロロホルムに溶解し、PPAR活性組成物を含有する抽出液とした。
<Adsorption process>
0.5 ml of the obtained extract was added to the following graphite carbon column, and further eluted with 20 mL of methanol. The eluate was concentrated to dryness to obtain an extract.
The obtained extract was dissolved in 5 mL of chloroform per 0.5 mL of the extract used to obtain an extract containing the PPAR active composition.
(グラファイトカーボンカラム)
カラムサイズ:φ12mm × 0.5cm、
充填剤:SampliQ Carbon SPE(アジレント社製炭素吸着材)
性状:非多孔質
比表面積:100m2/g
粒径:37〜125μm
使用量:500mg、
充填溶媒:メタノール
(Graphite carbon column)
Column size: φ12mm x 0.5cm,
Filler: SampliQ Carbon SPE (Agilent carbon adsorbent)
Property: Non-porous Specific surface area: 100 m 2 / g
Particle size: 37-125 μm
Amount used: 500 mg,
Filling solvent: methanol
尚、ここでは、グラファイトカーボンは非多孔質のものを採用している。この場合、比表面積は十分大きく、多孔質のものを用いるのに比べてPPAR活性組成物の低分子量化合物の非特異的吸着が排除される点で好ましいと考えられる。 In this case, non-porous graphite carbon is used. In this case, the specific surface area is sufficiently large, which is preferable in terms of eliminating nonspecific adsorption of the low molecular weight compound of the PPAR active composition as compared to using a porous material.
また、グラファイトカーボンの粒径は、小さすぎると、圧力損失が大きくなり溶出速度が遅くなり、大きすぎると溶出速度が速くなり除去効率が落ちるから、30〜400μmが好ましい。 Moreover, since the pressure loss will become large and the elution rate will become slow when the particle size of graphite carbon is too small, when it is too large, the elution rate will become high and removal efficiency will fall, and 30-400 micrometers is preferable.
<カラム分離工程>
前記抽出液1.0mLを10倍希釈した後、1.0mLを下記シリカゲルカラムクロマトグラフィーにて表1記載の溶媒を用いて21画分に分離した。各画分は濃縮乾固後、DMS0100μLに溶解し、抽出液とした。
<Column separation process>
After diluting 1.0 mL of the extract 10 times, 1.0 mL was separated into 21 fractions using the solvent described in Table 1 by silica gel column chromatography. Each fraction was concentrated to dryness and then dissolved in 0100 μL of DMS to obtain an extract.
(シリカゲルカラム)
カラムサイズ:φ12mm × 3cm、
充填剤:シリカゲル 60N(関東化学社製シリカゲル)
性状:球状、中性、
粒径:40−50μm
使用量:2.0g、
充填溶媒:クロロホルム
(Silica gel column)
Column size: φ12mm x 3cm,
Filler: Silica gel 60N (silica gel manufactured by Kanto Chemical Co., Inc.)
Properties: spherical, neutral,
Particle size: 40-50 μm
Amount used: 2.0 g
Filling solvent: Chloroform
〔PPAR活性〕
各画分についてPPARα活性を調べた結果を図1(グラファイトカーボンカラム処理)に示す。併せて、吸着工程を行うことなく、カラム分離工程を行って得られた抽出液(未処理)についての各画分のPPARα活性を示す。活性はEnBio RCAsforppARa(藤倉化成製)を用いて測定した。結合活性は、陽性対照物質GW7467(終濃度 500nM)の活性を100とした場合の相対活性(%)で表した。
[PPAR activity]
The results of examining PPARα activity for each fraction are shown in FIG. 1 (graphite carbon column treatment). In addition, the PPARα activity of each fraction of the extract (untreated) obtained by performing the column separation step without performing the adsorption step is shown. The activity was measured using EnBio RCAsforppARa (manufactured by Fujikura Kasei). The binding activity was expressed as a relative activity (%) when the activity of the positive control substance GW7467 (final concentration 500 nM) was defined as 100.
その結果、第11画分(図中Fr.11、以下同様に対応して記載する)付近でPPARα活性が高く、表2に示す濃縮乾固された各画分の重量分布からも、活性の高い物質は、主に第7画分〜第15画分付近で溶出していることがわかる。 As a result, the PPARα activity was high in the vicinity of the eleventh fraction (Fr.11 in the figure, correspondingly described below), and from the weight distribution of each of the concentrated and dried fractions shown in Table 2, the activity was also determined. It can be seen that high substances are eluted mainly in the vicinity of the seventh to fifteenth fractions.
ここで、図1を参照すると、第13〜第15画分のPPARα活性が、吸着工程により、大きく向上していることがわかる。全体としては、吸着工程の有無でPPARα活性が約3倍に向上していることが別途確認されている。すなわち、重量分布からはPPARα活性の高い物質が存在すると推定されるにもかかわらずPPARα活性が低い第13〜第15画分については、吸着工程を行わない場合に、何らかの物質による活性阻害が生じていることが予想され、吸着工程により、その物質が除去されているものと考えられる。また、同様に、他の画分にも活性阻害物質が含まれていることが考えられるが、他の画分に活性阻害物質が含まれていたとしても、その阻害物質が、カラム分離工程により有効に除去されることが明らかである。 Here, referring to FIG. 1, it can be seen that the PPARα activity of the 13th to 15th fractions is greatly improved by the adsorption process. As a whole, it has been separately confirmed that the PPARα activity is improved about 3 times with and without the adsorption step. That is, even if it is estimated from the weight distribution that a substance having high PPARα activity is present, the 13th to 15th fractions having low PPARα activity are inhibited by some substance when the adsorption step is not performed. It is expected that the substance has been removed by the adsorption process. Similarly, other fractions may contain an activity inhibitory substance, but even if other fractions contain an activity inhibitory substance, the inhibitory substance may be removed by the column separation process. It is clear that it is effectively removed.
したがって、イネ科植物抽出物をクロマトグラフ法により分離するカラム分離工程だけでは分離できない溶出成分を、炭素吸着材に接触させる吸着工程により有効に除去することができることがわかった。 Therefore, it was found that the elution components that cannot be separated only by the column separation step of separating the grass plant extract by the chromatographic method can be effectively removed by the adsorption step of contacting with the carbon adsorbent.
なお、吸着工程後の第11画分のLC/MS分析を行ったところ、既知のPPARα活性物質から生じるフラグメントピークが観測されないことから、今般抽出されたPPARα活性物質は、PPARα活性物質としては未知の物質であることが明らかになっている。また、阻害物質も未知であることから、炭素吸着材による吸着工程が活性向上に有用であることを見出した点については、今後イネ科植物抽出物を主成分とするPPAR活性組成物を利用するうえで有用である。 In addition, when LC / MS analysis of the eleventh fraction after the adsorption step was performed, a fragment peak generated from a known PPARα active substance was not observed, and thus the extracted PPARα active substance is unknown as a PPARα active substance. It has become clear that this is a substance. In addition, since the inhibitory substance is unknown, the PPAR active composition mainly composed of a grass plant extract will be used in the future for finding that the adsorption process using a carbon adsorbent is useful for activity improvement. It is useful in the above.
〔その他〕
上記実施例においては、吸着工程を行う場合にグラファイトカーボンを用いたが、一般的にグラファイトカーボンはカラムの充填剤として用いられ、種々物質に対する吸脱着性能を発揮するものと考えられる炭素質材料であるから、これに限らずグラファイトカーボンと同様の吸脱着性能を発揮するたとえば活性炭、モレキュラーシーブカーボン等の炭素質材料からなる炭素吸着材を用い、イネ科植物抽出物を炭素吸着材に接触させる吸着工程を行うことで同様の効果が期待できることが明らかである。
[Others]
In the above examples, graphite carbon was used in the adsorption step, but graphite carbon is generally used as a column filler and is a carbonaceous material considered to exhibit adsorption / desorption performance for various substances. Therefore, it is not limited to this, and adsorption using a carbon adsorbent made of a carbonaceous material such as activated carbon and molecular sieve carbon, which exhibits the same adsorption / desorption performance as graphite carbon, to bring the grass plant extract into contact with the carbon adsorbent It is clear that similar effects can be expected by performing the process.
また、イネ科植物としてサトウキビを用いたが同じイネ科の植物であれば同様のPPAR活性物質および阻害物質を含有していることが明らかであるので、ソルガム等他のイネ科植物を利用することも有効である。 In addition, sugarcane was used as the gramineous plant, but it is clear that the same gramineous plant contains the same PPAR active substance and inhibitor, so use other gramineous plants such as sorghum. Is also effective.
また、イネ科植物抽出物を炭素吸着材に接触させる吸着工程はクロマトグラフ法により分離し、PPAR活性阻害物質を除去するカラム分離工程の前に行ったが、吸着工程とカラム分離工程とは必ずしもこの順で行う必要はなく、逆に行ってもよい。また更に、本発明は、その他の分離工程を含むことを妨げるものではない。 In addition, the adsorption process in which the grass plant extract is brought into contact with the carbon adsorbent was separated by a chromatographic method and performed before the column separation process to remove the PPAR activity inhibitor, but the adsorption process and the column separation process are not necessarily performed. It is not necessary to perform in this order, and may be performed in reverse. Furthermore, the present invention does not prevent other separation steps from being included.
したがって、サトウキビ廃材等からより活性の高いPPARα活性成分を得ることができ、たとえば、メタボリックシンドローム改善の健康食品や飲料および医薬品としての活用が可能となる。
Therefore, it is possible to obtain a high PPAR alpha active ingredient the more active from sugar cane wastes, etc., for example, it is possible to use as a health food and beverage and pharmaceutical metabolic syndrome improved.
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014074190A JP6289218B2 (en) | 2014-03-31 | 2014-03-31 | Method for activating PPARα active composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014074190A JP6289218B2 (en) | 2014-03-31 | 2014-03-31 | Method for activating PPARα active composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015196651A JP2015196651A (en) | 2015-11-09 |
| JP6289218B2 true JP6289218B2 (en) | 2018-03-07 |
Family
ID=54546590
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014074190A Expired - Fee Related JP6289218B2 (en) | 2014-03-31 | 2014-03-31 | Method for activating PPARα active composition |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6289218B2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7659768B2 (en) * | 2019-07-23 | 2025-04-10 | 株式会社日清製粉グループ本社 | Lipid decomposition promoter, food and drink containing the same, and processed food for promoting lipid decomposition |
| WO2021167012A1 (en) * | 2020-02-18 | 2021-08-26 | 国立大学法人筑波大学 | Composition for neural function regulation |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1440688A4 (en) * | 2001-10-11 | 2005-11-30 | Kaneka Corp | Peroxisome proliferator activated receptor ligands and process for producing the same |
| JP2004161656A (en) * | 2002-11-12 | 2004-06-10 | Kanegafuchi Chem Ind Co Ltd | Peroxisome proliferator-activated receptor ligand agent |
| JP2006335741A (en) * | 2005-06-06 | 2006-12-14 | Kaneka Corp | Peroxisome proliferating agent-responsive receptor ligand composition derived from plant belonging to genus amorphophallus |
| JP2009263257A (en) * | 2008-04-23 | 2009-11-12 | Kao Corp | Agent for preventing and/or improving fatty liver |
| JP2013193987A (en) * | 2012-03-19 | 2013-09-30 | Osaka Gas Co Ltd | Ppar active composition |
| JP2015189742A (en) * | 2014-03-28 | 2015-11-02 | 大阪瓦斯株式会社 | Ppar activity composition and energy production facility |
-
2014
- 2014-03-31 JP JP2014074190A patent/JP6289218B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2015196651A (en) | 2015-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zhao et al. | Supercritical CO2 extraction of Eucalyptus leaves oil and comparison with Soxhlet extraction and hydro-distillation methods | |
| Ben-Youssef et al. | Green extraction procedures of lipids from Tunisian date palm seeds | |
| Virot et al. | Total lipid extraction of food using d-limonene as an alternative to n-hexane | |
| De Oliveira et al. | The extraction of passion fruit oil with green solvents | |
| Asif et al. | Isolation of high-quality RNA from apple (Malus domestica) fruit | |
| Tavakolpour et al. | Comparison of four extraction methods for essential oil from Thymus daenensis Subsp. Lancifolius and chemical analysis of extracted essential oil | |
| Yang et al. | Anti-thrombotic effects of α-linolenic acid isolated from Zanthoxylum bungeanum Maxim seeds | |
| Hammann et al. | Method development for the determination of free and esterified sterols in button mushrooms (Agaricus bisporus) | |
| Warra | Sesame (Sesamum indicum L.) seed oil methods of extraction and its prospects in cosmetic industry: a review | |
| JP6289218B2 (en) | Method for activating PPARα active composition | |
| Park | Isolation and characterization of N-feruloyltyramine as the P-selectin expression suppressor from garlic (Allium sativum) | |
| Dali et al. | Extraction of lyophilized olive mill wastewater using supercritical CO2 processes | |
| Kurtovic et al. | The use of immobilised digestive lipase from Chinook salmon (Oncorhynchus tshawytscha) to generate flavour compounds in milk | |
| Lima et al. | Volatile compounds and palynological analysis from pollen pots of stingless bees from the mid-north region of Brazil | |
| Anggard et al. | Formation of prostaglandins in the skin following a burn injury | |
| Min et al. | Supercritical CO2 extraction of Jatropha oil and solubility correlation | |
| Pineda et al. | The origin of aliphatic hydrocarbons in olive oil | |
| Barberini et al. | Molecular cloning of SoHPPR encoding a hydroxyphenylpyruvate reductase, and its expression in cell suspension cultures of Salvia officinalis | |
| Nikolaeva et al. | Lipids from Orostachys spinosa | |
| Gawrysiak‐Witulska et al. | Degradation of phytosterols during near‐ambient drying of rapeseeds in a thick immobile layer | |
| Anisa et al. | Temperature effects on diffusion coefficient for 6-gingerol and 6-shogaol in subcritical water extraction | |
| Chen et al. | Hypolipidaemic effect and mechanism of paprika seed oil on Sprague–Dawley rats | |
| Nautiyal et al. | Extraction of dill seed oil (Anethum sowa) using supercritical carbon dioxide and comparison with hydrodistillation | |
| Govindarasu et al. | Intensified extraction of geraniol from palmarosa leaves using diverse hydrotrope-assisted extraction techniques | |
| CN105177073B (en) | A kind of method for preparing phosphatidylserine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20161207 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170926 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20170927 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20171120 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20180109 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20180206 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6289218 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| LAPS | Cancellation because of no payment of annual fees |